Unknown

Dataset Information

0

Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection.

ABSTRACT: In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.

SUBMITTER: Bosserman RE 

PROVIDER: S-EPMC9726486 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection.

Bosserman Rachel E RE   Farnsworth Christopher W CW   O'Neil Caroline A CA   Cass Candice C   Park Daniel D   Ballman Claire C   Wallace Meghan A MA   Struttmann Emily E   Stewart Henry H   Arter Olivia O   Peacock Kate K   Fraser Victoria J VJ   Budge Philip J PJ   Olsen Margaret A MA   Burnham Carey-Ann D CD   Babcock Hilary M HM   Kwon Jennie H JH  

Antimicrobial stewardship & healthcare epidemiology : ASHE 20220615 1

In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit. ...[more]

Similar Datasets

Unknown Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020-April 2021.
| S-EPMC10428156 | biostudies-literature
Unknown Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel.
| S-EPMC9129106 | biostudies-literature
Unknown An update of antispike severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies.
| S-EPMC9012417 | biostudies-literature
Unknown Large-Scale Testing of Asymptomatic Healthcare Personnel for Severe Acute Respiratory Syndrome Coronavirus 2.
| S-EPMC7774535 | biostudies-literature
Unknown Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
| S-EPMC7448950 | biostudies-literature
Transcriptomics Culturing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnosis and genome sequencing
2022-06-29 | GSE189731 | GEO
Unknown Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Previously Infected Healthcare Personnel and First Responders.
| S-EPMC8767877 | biostudies-literature
Unknown Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting.
| S-EPMC6778978 | biostudies-literature
Unknown Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya.
| S-EPMC8135298 | biostudies-literature
Unknown Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study.
| S-EPMC8886081 | biostudies-literature